Rothschild & Co. Asset Management US Inc. boosted its position in UnitedHealth Group Inc (NYSE:UNH) by 0.3% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 287,014 shares of the healthcare conglomerate’s stock after purchasing an additional 993 shares during the quarter. UnitedHealth Group comprises about 0.8% of Rothschild & Co. Asset Management US Inc.’s holdings, making the stock its 13th largest position. Rothschild & Co. Asset Management US Inc.’s holdings in UnitedHealth Group were worth $76,357,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in UNH. FNY Investment Advisers LLC acquired a new position in shares of UnitedHealth Group during the 3rd quarter valued at about $106,000. Welch Group LLC acquired a new position in shares of UnitedHealth Group during the 2nd quarter valued at about $106,000. Polaris Greystone Financial Group LLC acquired a new position in shares of UnitedHealth Group during the 3rd quarter valued at about $120,000. Fort L.P. acquired a new position in shares of UnitedHealth Group during the 2nd quarter valued at about $119,000. Finally, Columbia Asset Management acquired a new position in shares of UnitedHealth Group during the 3rd quarter valued at about $152,000. 85.57% of the stock is owned by hedge funds and other institutional investors.

A number of research analysts have recently commented on the stock. Zacks Investment Research downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, November 29th. Raymond James set a $310.00 price objective on shares of UnitedHealth Group and gave the company a “buy” rating in a research note on Wednesday, November 28th. Oppenheimer upped their price objective on shares of UnitedHealth Group from $295.00 to $300.00 and gave the company an “outperform” rating in a research note on Wednesday, November 28th. Piper Jaffray Companies upped their price objective on shares of UnitedHealth Group to $312.00 and gave the company an “overweight” rating in a research note on Wednesday, November 28th. Finally, BMO Capital Markets set a $310.00 price objective on shares of UnitedHealth Group and gave the company a “buy” rating in a research note on Tuesday, November 27th. Two investment analysts have rated the stock with a hold rating and twenty-one have issued a buy rating to the company. The stock has an average rating of “Buy” and a consensus target price of $292.48.

In other UnitedHealth Group news, Director Richard T. Burke sold 6,090 shares of the company’s stock in a transaction that occurred on Wednesday, November 28th. The stock was sold at an average price of $281.72, for a total value of $1,715,674.80. Following the completion of the transaction, the director now owns 1,711,584 shares in the company, valued at approximately $482,187,444.48. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Richard T. Burke sold 20,000 shares of the company’s stock in a transaction that occurred on Wednesday, September 12th. The stock was sold at an average price of $263.41, for a total value of $5,268,200.00. Following the completion of the transaction, the director now owns 1,720,112 shares of the company’s stock, valued at approximately $453,094,701.92. The disclosure for this sale can be found here. In the last 90 days, insiders sold 60,428 shares of company stock valued at $16,232,134. 0.87% of the stock is owned by company insiders.

Shares of NYSE:UNH opened at $278.55 on Wednesday. The company has a debt-to-equity ratio of 0.61, a current ratio of 0.69 and a quick ratio of 0.69. UnitedHealth Group Inc has a 1 year low of $208.48 and a 1 year high of $287.94. The stock has a market cap of $270.68 billion, a PE ratio of 27.66, a PEG ratio of 1.65 and a beta of 0.76.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 16th. The healthcare conglomerate reported $3.41 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $3.30 by $0.11. The business had revenue of $56.56 billion during the quarter, compared to analysts’ expectations of $56.34 billion. UnitedHealth Group had a return on equity of 23.62% and a net margin of 5.71%. The company’s revenue for the quarter was up 12.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.66 EPS. As a group, sell-side analysts forecast that UnitedHealth Group Inc will post 12.82 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 13th. Shareholders of record on Monday, December 3rd will be issued a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a yield of 1.29%. The ex-dividend date is Friday, November 30th. UnitedHealth Group’s dividend payout ratio is presently 35.75%.

ILLEGAL ACTIVITY NOTICE: “Rothschild & Co. Asset Management US Inc. Has $76.36 Million Position in UnitedHealth Group Inc (UNH)” was published by Watch List News and is the property of of Watch List News. If you are viewing this piece of content on another domain, it was illegally copied and reposted in violation of U.S. & international trademark & copyright law. The original version of this piece of content can be accessed at https://www.watchlistnews.com/rothschild-co-asset-management-us-inc-has-76-36-million-position-in-unitedhealth-group-inc-unh/2662822.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Recommended Story: What is intrinsic value?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.